Public notice

Research on the immunomodulatory imide drugs development under the Cooperative Research and Development Agreement(CRADA) with the National Institutes of Health(NIH) have been published in the peer-reviewed publication, Frontiers in Neuroscience(March 2)

관리자 │ 2023-01-17

HIT

457

Research on the immunomodulatory imide drugs development under the Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health (NIH) have been published in the peer-reviewed publication, Frontiers in Neuroscience (March 29, 2021).



The publication, titled, “Repurposing immunomodulatory imide drugs (IMiDs) in neuropsychiatric and neurodegenerative disorders” may be found here (https://elifesciences.org/articles/54726).




Previous Post The therapeutic efficacy results of a candidate immunomodulatory imide drug deve...
Next Post The therapeutic efficacy results of a candidate immunomodulatory imide drug deve...